SARS-CoV2 wild type and mutant specific humoral and T cell immunity is superior after vaccination than after natural infection.
<h4>Objective</h4>We investigated blood samples from fully SARS-CoV2-vaccinated subjects and from previously positive tested patients up to one year after infection with SARS-CoV2, and compared short- and long-term T cell and antibody responses, with a special focus on the recently emerg...
Main Authors: | Jennifer R Richardson, Ralph Götz, Vanessa Mayr, Martin J Lohse, Hans-Peter Holthoff, Martin Ungerer |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0266701 |
Similar Items
-
Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
by: David Peterhoff, et al.
Published: (2023-10-01) -
Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients
by: Agata Błaszczuk, et al.
Published: (2023-03-01) -
Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
by: Krystallenia Paniskaki, et al.
Published: (2022-10-01) -
Humoral immunogenicity assessment after receiving three types of SARS-CoV-2 vaccine
by: Niloofar Najafi, et al.
Published: (2023-11-01) -
Humoral response to SARS-CoV-2 after vaccination and booster effect in patients undergoing dialysis
by: Miriam Hernández-Porto, et al.
Published: (2022-09-01)